Shots: The company has reported the results from Part 2 of the FIREFISH study evaluating the efficacy and safety of Evrysdi in 41 infants aged 1-7 mos. with symptomatic Type […]readmore
Tags : FIREFISH Study
Shots: Roche has reported the data from the dose-finding Part 1 of the FIREFISH study assessing Evrysdi in patients aged 1-7mos. with Type 1 SMA. Part 1 evaluated several doses […]readmore
Shots: The FIREFISH study involves assessing of Risdiplam in infants aged 1-7 mos. with Type 1 SMA The P-II FIREFISH study results: met its 1EPs i.e, the proportion of infants […]readmore